`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`MYLAN PHARMACEUTICALS INC., CELLTRION, INC., and
`APOTEX, INC.,
`Petitioners,
`
`
`
`
`
`v.
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner.
`
`
`Inter Partes Review No.: IPR2021-008811
`
`
`U.S. Patent No. 9,254,338 B2
`Filed: July 12, 2013
`Issued: February 9, 2016
`Inventor: George D. Yancopoulos
`
`Title: USE OF A VEGF ANTAGONIST TO TREAT
`ANGIOGENIC EYE DISORDERS
`
`
`PETITIONER’S REQUEST FOR ORAL ARGUMENT
`PURSUANT TO 37 C.F.R. § 42.70(a)
`
`
`
`
`
`
`
`
`
`
`
`
`
`1 IPR2022-00258 and IPR2022-00298 have been joined with this proceeding.
`
`
`
`Pursuant to 37 C.F.R. § 42.70(a) and the Board’s Revised Joint Scheduling
`
`Order, dated March 23, 2022 (Paper 48), Petitioner Mylan Pharmaceuticals, Inc.
`
`(“Petitioner”) hereby submits this Request for Oral Argument on issues related to
`
`the patentability of claims 1, 3-11, 13-14, 16-24, and 26 of U.S. Patent No.
`
`9,254,338 B2. Petitioner intends to discuss the issues raised in the parties’ papers
`
`in this proceeding and the Board’s Institution Decision, dated November 10, 2021
`
`(Paper 21), as well as any other issues the Board deems necessary for issuing a Final
`
`Written Decision.
`
`The Board has scheduled an oral argument for August 10, 2022, for this
`
`proceeding as well as in related proceeding IPR2021-00880 (U.S. Patent No.
`
`9,669,069). See Paper 48, 1 n.3, 5. Petitioner proposes that separate oral argument
`
`is unnecessary given the significant overlap between the two proceedings.
`
`Accordingly, in an effort to maximize efficiency and preserve the Board’s
`
`resources, Petitioner respectfully requests the Board consolidate the oral argument
`
`for this proceeding (IPR2021-00881) with the oral argument for related proceeding
`
`IPR2021-00880. Petitioner further requests that the Board allot 90 minutes total for
`
`the consolidated oral argument, which would be divided equally between the parties
`
`(45 minutes per side). Petitioner and Patent Owner have met and conferred on the
`
`subject of oral argument. It is Petitioner’s understanding that Patent Owner does
`
`not agree with the above proposal.
`
`
`
`2
`
`
`
`Petitioner further requests that the consolidated oral argument take place in-
`
`person at the USPTO’s headquarters in Alexandria, Virginia. Petitioner requests
`
`that in-house counsel and any other non-arguing attorneys be permitted to attend
`
`the consolidated oral argument remotely. Petitioner will advise the Board as to any
`
`audio/video request as soon as practicable.
`
`
`
`Dated: July 8, 2022
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`
`/Paul J. Molino/
`Paul J. Molino
`Registration No. 45,350
`6 West Hubbard Street
`Chicago, IL 60654
`Telephone:
`(312) 222-6300
`Facsimile:
`(312) 843-6260
`paul@rmmslegal.com
`
`
`Counsel for Petitioner
`
`
`
`
`3
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true and correct copy of the foregoing
`
`Petitioner’s Request for Oral Argument Pursuant to 37 C.F.R. § 42.70(a) was served
`
`on July 8, 2022, via electronic mail by agreement of the parties, to the following
`
`counsel of record for Patent Owners:
`
`Alice S. Ho (Lim. Rec. No. L1162)
`Victoria Reines
`Jeremy Cobb
`Arnold & Porter Kaye Scholer LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Tel: 202.942.5000
`Fax: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Jeremy.Cobb@arnoldporter.com
`
`
`
`/Paul J. Molino/
`Paul J. Molino (Reg. No. 45,350)
`
`Deborah E. Fishman (Reg. No. 48,621)
`David A. Caine (Reg. No. 52,683)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Telephone: 650.319.4710
`Facsimile: 650.319.4573
`Deborah.Fishman@arnoldporter.com
`David.Caine@arnoldporter.com
`RegeneronEyleaIPRs@arnoldporter.com
`
`Daniel Reisner
`Matthew M. Wilk
`Arnold & Porter Kaye Scholer LLP
`250 West 55th Street
`New York, New York 10019-9710
`Telephone: 212.836.8000
`Fax: 212.836.8689
`Daniel.Reisner@arnoldporter.com
`Matthew.Wilk@arnoldporter.com
`
`
`
`
`